Zeria Pharmaceutical Co., Ltd. (4559.T)
JPY 2233.0
(-0.62%)
JPY 2233.0
(-0.62%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 9.71 Billion JPY | 7.78% |
| 2022 | 9.01 Billion JPY | 41.61% |
| 2021 | 6.36 Billion JPY | 84.95% |
| 2020 | 3.44 Billion JPY | -15.94% |
| 2019 | 4.09 Billion JPY | 9.57% |
| 2018 | 3.73 Billion JPY | -22.63% |
| 2017 | 4.83 Billion JPY | 6.36% |
| 2016 | 4.54 Billion JPY | -0.53% |
| 2015 | 4.56 Billion JPY | 70.45% |
| 2014 | 2.67 Billion JPY | -60.55% |
| 2013 | 6.79 Billion JPY | 47.25% |
| 2012 | 4.61 Billion JPY | 0.93% |
| 2011 | 4.56 Billion JPY | 37.97% |
| 2010 | 3.31 Billion JPY | 109.04% |
| 2009 | 1.58 Billion JPY | 19.6% |
| 2008 | 1.32 Billion JPY | -48.26% |
| 2007 | 2.56 Billion JPY | -25.54% |
| 2006 | 3.43 Billion JPY | 76.84% |
| 2005 | 1.94 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 3.93 Billion JPY | 2862.14% |
| 2023 Q1 | 2.97 Billion JPY | 539.75% |
| 2023 FY | 9.71 Billion JPY | 7.78% |
| 2023 Q3 | 4.16 Billion JPY | 76.61% |
| 2023 Q2 | 2.35 Billion JPY | -20.63% |
| 2023 Q4 | 132.97 Million JPY | -96.81% |
| 2022 Q3 | 2.65 Billion JPY | -8.96% |
| 2022 Q1 | 2.97 Billion JPY | 242.07% |
| 2022 FY | 9.01 Billion JPY | 41.61% |
| 2022 Q4 | 464.27 Million JPY | -82.52% |
| 2022 Q2 | 2.91 Billion JPY | -2.0% |
| 2021 Q3 | 2.82 Billion JPY | 98.72% |
| 2021 FY | 6.36 Billion JPY | 84.95% |
| 2021 Q1 | 1.25 Billion JPY | 401.72% |
| 2021 Q2 | 1.42 Billion JPY | 13.49% |
| 2021 Q4 | 870.32 Million JPY | -69.17% |
| 2020 Q3 | 2.25 Billion JPY | 319.36% |
| 2020 FY | 3.44 Billion JPY | -15.94% |
| 2020 Q1 | 1.06 Billion JPY | 48.87% |
| 2020 Q4 | -414.88 Million JPY | -118.37% |
| 2020 Q2 | 538.53 Million JPY | -49.2% |
| 2019 Q4 | 712.08 Million JPY | -56.68% |
| 2019 Q3 | 1.64 Billion JPY | 301.65% |
| 2019 Q2 | 409.25 Million JPY | -69.22% |
| 2019 FY | 4.09 Billion JPY | 9.57% |
| 2019 Q1 | 1.32 Billion JPY | 96.7% |
| 2018 FY | 3.73 Billion JPY | -22.63% |
| 2018 Q4 | 676 Million JPY | -31.83% |
| 2018 Q3 | 991.58 Million JPY | 127.12% |
| 2018 Q2 | 436.59 Million JPY | -73.26% |
| 2018 Q1 | 1.63 Billion JPY | 572.56% |
| 2017 Q4 | 242.78 Million JPY | -88.93% |
| 2017 FY | 4.83 Billion JPY | 6.36% |
| 2017 Q3 | 2.19 Billion JPY | 22.13% |
| 2017 Q2 | 1.79 Billion JPY | 200.92% |
| 2017 Q1 | 597.02 Million JPY | -33.68% |
| 2016 Q2 | 1.42 Billion JPY | -17.03% |
| 2016 Q1 | 1.72 Billion JPY | 122.63% |
| 2016 Q4 | 900.25 Million JPY | 82.73% |
| 2016 Q3 | 492.67 Million JPY | -65.5% |
| 2016 FY | 4.54 Billion JPY | -0.53% |
| 2015 Q3 | 1.67 Billion JPY | 54.45% |
| 2015 Q1 | 1.02 Billion JPY | 255.32% |
| 2015 FY | 4.56 Billion JPY | 70.45% |
| 2015 Q4 | 772.94 Million JPY | -53.95% |
| 2015 Q2 | 1.08 Billion JPY | 5.74% |
| 2014 FY | 2.67 Billion JPY | -60.55% |
| 2014 Q3 | 1.06 Billion JPY | -25.34% |
| 2014 Q2 | 1.42 Billion JPY | 65.59% |
| 2014 Q1 | 858.2 Million JPY | 4.12% |
| 2014 Q4 | -661.63 Million JPY | -162.36% |
| 2013 FY | 6.79 Billion JPY | 47.25% |
| 2013 Q4 | 824.2 Million JPY | -56.73% |
| 2013 Q3 | 1.9 Billion JPY | 57.81% |
| 2013 Q2 | 1.2 Billion JPY | -57.7% |
| 2013 Q1 | 2.85 Billion JPY | 152.86% |
| 2012 Q3 | 1.55 Billion JPY | 50.32% |
| 2012 Q4 | 1.12 Billion JPY | -27.3% |
| 2012 Q2 | 1.03 Billion JPY | 15.08% |
| 2012 FY | 4.61 Billion JPY | 0.93% |
| 2012 Q1 | 897.45 Million JPY | 898.92% |
| 2011 Q1 | 1.4 Billion JPY | 148.69% |
| 2011 FY | 4.56 Billion JPY | 37.97% |
| 2011 Q2 | 1.27 Billion JPY | -9.13% |
| 2011 Q3 | 1.99 Billion JPY | 55.71% |
| 2011 Q4 | -112.33 Million JPY | -105.64% |
| 2010 Q1 | 352.51 Million JPY | 104.01% |
| 2010 Q4 | 566.33 Million JPY | -37.0% |
| 2010 Q2 | 1.48 Billion JPY | 322.68% |
| 2010 FY | 3.31 Billion JPY | 109.04% |
| 2010 Q3 | 898.93 Million JPY | -39.67% |
| 2009 Q4 | 172.79 Million JPY | -62.12% |
| 2009 Q3 | 456.11 Million JPY | -41.62% |
| 2009 Q2 | 781.25 Million JPY | 356.27% |
| 2009 Q1 | 171.22 Million JPY | -28.38% |
| 2009 FY | 1.58 Billion JPY | 19.6% |
| 2008 Q2 | 725.63 Million JPY | 0.0% |
| 2008 Q3 | 118.23 Million JPY | -83.71% |
| 2008 FY | 1.32 Billion JPY | -48.26% |
| 2008 Q4 | 239.06 Million JPY | 102.19% |
| 2007 FY | 2.56 Billion JPY | -25.54% |
| 2006 FY | 3.43 Billion JPY | 76.84% |
| 2005 FY | 1.94 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 5.11 Billion JPY | -90.038% |
| Takeda Pharmaceutical Company Limited | 214.07 Billion JPY | 95.461% |
| Sumitomo Pharma Co., Ltd. | -354.19 Billion JPY | 102.743% |
| Shionogi & Co., Ltd. | 171.46 Billion JPY | 94.333% |
| Wakamoto Pharmaceutical Co.,Ltd. | -195.51 Million JPY | 5069.872% |
| Nippon Shinyaku Co., Ltd. | 31.38 Billion JPY | 69.041% |
| Kaken Pharmaceutical Co., Ltd. | 9.51 Billion JPY | -2.141% |
| Eisai Co., Ltd. | 53.4 Billion JPY | 81.807% |
| Morishita Jintan Co., Ltd. | 716 Million JPY | -1257.073% |
| Hisamitsu Pharmaceutical Co., Inc. | 13.16 Billion JPY | 26.205% |
| Mochida Pharmaceutical Co., Ltd. | 5.8 Billion JPY | -67.442% |
| Fuso Pharmaceutical Industries,Ltd. | 1.96 Billion JPY | -394.738% |
| Nippon Chemiphar Co., Ltd. | -494 Million JPY | 2066.932% |
| Tsumura & Co. | 20.01 Billion JPY | 51.46% |
| Kissei Pharmaceutical Co., Ltd. | 4.01 Billion JPY | -141.888% |
| Torii Pharmaceutical Co., Ltd. | 5.03 Billion JPY | -92.944% |
| Towa Pharmaceutical Co., Ltd. | 17.64 Billion JPY | 44.942% |
| Fuji Pharma Co., Ltd. | 3.85 Billion JPY | -151.857% |
| KYORIN Holdings, Inc. | 6.01 Billion JPY | -61.594% |
| Taiko Pharmaceutical Co.,Ltd. | -3.07 Billion JPY | 415.578% |
| Daito Pharmaceutical Co.,Ltd. | 3.89 Billion JPY | -149.529% |
| SymBio Pharmaceuticals Limited | -811.66 Million JPY | 1297.121% |
| MedRx Co., Ltd | -933 Million JPY | 1141.441% |
| Mizuho Medy Co.,Ltd. | 5.15 Billion JPY | -88.6% |
| Solasia Pharma K.K. | -1.13 Billion JPY | 953.086% |
| Modalis Therapeutics Corporation | -2.37 Billion JPY | 509.985% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 6.5 Billion JPY | -49.487% |
| Sawai Group Holdings Co., Ltd. | 18.88 Billion JPY | 48.551% |
| Cyfuse Biomedical K.K. | -697.43 Million JPY | 1493.193% |
| Toho Holdings Co., Ltd. | 19.33 Billion JPY | 49.735% |
| Koa Shoji Holdings Co.,Ltd. | 4.38 Billion JPY | -121.724% |